Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes

Current Eye Research

Volumn 36, Issue 1, 2011, Pages 41-46

  Wang, Rong Fang ^a   Podos, Steven M ^a   Serle, Janet B ^a   Baltatu, Ovidiu C ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Avosentan (SPP 301); Endothelin Antagonist; Glaucoma monkey; Intraocular pressure

Indexed keywords

AVOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EYE DISCHARGE; FEMALE; GLAUCOMA; HAPLORHINI; INTRAOCULAR PRESSURE; MULTIPLE DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; SLIT LAMP;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; PYRIDINES; PYRIMIDINES; RECEPTORS, ENDOTHELIN; TONOMETRY, OCULAR;

EID: 78650450684     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.512695     Document Type: Article

References (18)

1. Prasanna G, Narayan S, Krishnamoorthy RR, et al. Eyeing endothelins: A cellular perspective. Molecular & Cellular Biochem. 2003;243:71-88.
2. Yorio T, Krishnamoorthy RR, Prasanna G. Endothelin: Is it a contributor to glaucoma pathophysiology? J Glaucoma. 2002;11:259-270.
3. Orgul S, Cioff GA, Bacon DR, et al. An endothelin-1 induced model of chronic optic nerve ischemia in rhesus monkeys. J Glaucoma. 1996;5:135-138. (Pubitemid 26139165)
4. Balwantray CC. Model of chronic endothelin-induced optic nerve damage in rat. Exp Eye Res. 2000;17:S24.
5. Kallberg ME, Brooks DE, Allis AE, et al. Correlation of retinal damage to endothelin 1 levels in the aqueous humor and vitreous in dogs with spontaneous hypertensive glaucoma. Invest Ophthalmol Vis Sci. 2002;43:E-Abstract 312.
6. Thieme H, Schimmat C, Munzer G, et al. Endothelin antagonism: Effects of FP receptor agonist prostaglandin F2α and fuprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci. 2006;47:938-945.
7. Sugiyama T, Moriya S, Oku H, et al. Association of endothe-lin-1 with normal tension glaucoma. Surv Ophthalmol. 1995;39:S49-S56.
8. Kaiser HJ, Flammer J, Wenk M, et al. Endothelin-1 plasma level in normal tension glaucoma: Abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol. 1995;233:484-488.
9. Lepple-Wienhues A, Becker M, Stahl F, et al. Endothelin-like immunoreactivity in the aqueous humor and in conditioned medium from cultures ciliary epithelial cells. Curr Eye Res. 1992;11:1041-1046.
10. Koliakos GG, Konstas AGP, Schlotzer-Schrehardt U, et al. Endothelin-1 concentration in the aqueous humor with exfoliation syndrome. Br J Ophthalmol. 2004;88: 523-527.
11. Choritz L, Machert M, Pfeiffer N, et al. Endothelin-1 concentration in aqueous humor, but not in blood plasma correlate with IOP. Invest Ophthalmol Vis Sci. 2009;50:E-Abstract 4862.
12. Polak K, Luksch A, Frank B, et al. Regulation of human retinal blood fow by endothelin-1. Exp Eye Res. 2003;76:633-640.
13. Polak K, Petternel V, Luksch A, et al. Effect of endothelin and BQ123 on ocular blood fow parameters in healthy subjects. Invest Ophthalmol Vis Sci. 2001;42:2949-2956.
14. Wang RF, Schumer RA, Serle SB, et al. A comparison of argon laser and diode laser photocoagulations of the trabe-cular meshwork to produce the glaucoma monkey model. J Glaucoma. 1998;7:45-49.
15. Flammer J, Pache M, Resink T. Vasospasm: Its role in the pathogenesis of diseases with particular reference to the eyes. Prog Retina Eye Res. 2001;20:319-349.
16. Hollo G, Kothy P, Lakatos P, et al. Endothelin-A receptor antagonist BQ-485 protects against intraocular pressure spike induced by laser trabeculoplasty in rabbits. Ophthalmologica. 2002;216:459-462.
17. Resch H, Karl K, Weigert G, et al. Effect of dual endothe-lin receptor blockade on ocular blood fow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2009;50:358-363.
18. Henry E, Newby DE, Webb DJ, et al. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest Ophthalmol Vis Sci. 2006;47:2528-2532.